Jan 25th, 2023 - Tools such as ChatGPT threaten transparent science; here are our ground rules for their use.|2023||ethics,legislation & jurisprudence,trends,ethics,legislation & jurisprudence,standards,ethics,methods,standards,standards,standards,
Nature Mallapaty S
Jan 19th, 2023 - China is opening up after 3 years - what does it mean for research?|2023|Mallapaty S,|epidemiology,epidemiology,legislation & jurisprudence,trends,organization & administration,trends,
Nature Else H
Jan 19th, 2023 - Multimillion-dollar trade in paper authorships alarms publishers.|2023|Else H,|standards,economics,ethics,legislation & jurisprudence,standards,economics,ethics,legislation & jurisprudence,statistics & numerical data,
Nature Stokel-Walker C
Jan 19th, 2023 - ChatGPT listed as author on research papers: many scientists disapprove.|2023|Stokel-Walker C,|legislation & jurisprudence,trends,legislation & jurisprudence,trends,standards,trends,
Journal of Religion and Health; Avci E
Jan 18th, 2023 - All religions should develop convincing responses to emerging bioethical problems stemming from medical and technological advancements. Additionally, believers need to know their faiths' interpretations of bioethical issues to be able to make medical decisions in line with their religious values. Therefore, Islamic bioethics should provide Muslims with conclusive and credible answers regarding ...
The New England Journal of Medicine; Kumar W, Schulman K
Jan 18th, 2023 - Medicare Overpayment for Outpatient Medication - A Supreme Court Ruling in Context.|2023|Kumar W,Schulman K,|economics,legislation & jurisprudence,economics,economics,
Nature Kozlov M
Jan 14th, 2023 - Researchers blast US agency's decision not to collect LGBT+ data.|2023|Kozlov M,|statistics & numerical data,legislation & jurisprudence,
Nature Tollefson J
Jan 13th, 2023 - The plan to 'Trump-proof' US science against political meddling.|2023|Tollefson J,|ethics,legislation & jurisprudence,standards,
JAMA Kadakia KT, Dhruva SS et. al.
Jan 11th, 2023 - In the US, nearly all medical devices progress to market under the 510(k) pathway, which uses previously authorized devices (predicates) to support new authorizations. Current regulations permit manufacturers to use devices subject to a Class I recall-the FDA's most serious designation indicating a high probability of adverse health consequences or death-as predicates for new devices. The conse...
JAMA Everhart AO, Sen S et. al.
Jan 11th, 2023 - Most regulated medical devices enter the US market via the 510(k) regulatory submission pathway, wherein manufacturers demonstrate that applicant devices are "substantially equivalent" to 1 or more "predicate" devices (legally marketed medical devices with similar intended use). Most recalled medical devices are 510(k) devices. To examine the association between characteristics of predicate med...
Nature Rodrigues M
Jan 8th, 2023 - Will Brazil's President Lula keep his climate promises?|2023|Rodrigues M,|legislation & jurisprudence,
JAMA Goodman KE, Morgan DJ et. al.
Jan 6th, 2023 - Clinical Algorithms, Antidiscrimination Laws, and Medical Device Regulation.|2023|Goodman KE,Morgan DJ,Hoffmann DE,|legislation & jurisprudence,prevention & control,legislation & jurisprudence,methods,
JAMA Feldman WB, Tu SS et. al.
Jan 4th, 2023 - Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021.|2023|Feldman WB,Tu SS,Alhiary R,Kesselheim AS,Wouters OJ,|economics,economics,legislation & jurisprudence,economics,legislation & jurisprudence,
The New England Journal of Medicine; Glicksman RL
Dec 23rd, 2022 - Protecting the Public Health with the Inflation Reduction Act - Provisions Affecting Climate Change and Its Health Effects.|2022|Glicksman RL,|legislation & jurisprudence,legislation & jurisprudence,
AJNR. American Journal of Neuroradiology; Nguyen TH, Heller RE et. al.
Dec 23rd, 2022 - The No Surprises Act: What Neuroradiologists Should Know.|2022|Nguyen TH,Heller RE,Keysor K,Milburn JM,Rula EY,|legislation & jurisprudence,standards,economics,
JAMA Peachman RR
Dec 22nd, 2022 - Will the New CDC Opioid Prescribing Guidelines Help Correct the Course in Pain Care?|2022|Peachman RR,|therapeutic use,legislation & jurisprudence,standards,drug therapy,standards,standards,drug therapy,
JAMA Rubin R
Dec 21st, 2022 - Illegal e-Cigarettes Targeting Youth.|2022|Rubin R,|legislation & jurisprudence,legislation & jurisprudence,legislation & jurisprudence,
The New England Journal of Medicine; Singh H, Eckelman M et. al.
Dec 15th, 2022 - Mandatory Reporting of Emissions to Achieve Net-Zero Health Care.|2022|Singh H,Eckelman M,Berwick DM,Sherman JD,|legislation & jurisprudence,legislation & jurisprudence,legislation & jurisprudence,
Cognition Kneer M, Skoczeń I
Dec 15th, 2022 - In a series of ten preregistered experiments (N = 2043), we investigate the effect of outcome valence on judgments of probability, negligence, and culpability - a phenomenon sometimes labelled moral (and legal) luck. We found that harmful outcomes, when contrasted with neutral outcomes, lead to an increased perceived probability of harm ex post, and consequently, to a greater attribution of neg...
JAMA Kressin NR, Slanetz PJ et. al.
Dec 13th, 2022 - Ensuring Clarity and Understandability of the FDA's Breast Density Notifications.|2022|Kressin NR,Slanetz PJ,Gunn CM,|diagnostic imaging,diagnostic imaging,standards,legislation & jurisprudence,standards,